UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets

The Journal of biological chemistry, 1998-06, Vol.273 (24), p.15061-15068

1998

Volltextzugriff (PDF)

Proteolytically Activated Receptor-3: A Member of an Emerging Gene Family of Protease Receptors Expressed on Vascular Endothelial Cells and Platelets

Trends in cardiovascular medicine, 1999-01, Vol.9 (1), p.42-48

1999

Volltextzugriff (PDF)

Platelets express steroidogenic 17β–hydroxysteroid dehydrogenases: Distinct profiles predict the essential thrombocythemic phenotype

Thrombosis and haemostasis, 2005-08, Vol.94 (8), p.412-421

2005

Volltextzugriff (PDF)

IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization

Blood, 2003-04, Vol.101 (8), p.3021-3028

2003

Volltextzugriff (PDF)

Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells

Experimental hematology, 2004-10, Vol.32 (10), p.991-999

2004

Volltextzugriff (PDF)

Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization

Mammalian genome, 2004-08, Vol.15 (8), p.618-629

2004

Volltextzugriff (PDF)

The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand

Nature communications, 2017-12, Vol.8 (1), p.1910-7, Article 1910

2017

Volltextzugriff (PDF)

Figures de la Cruauté

1, 2012

Volltextzugriff (PDF)

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Cancer, 2010-03, Vol.116 (5), p.1272-1280

2010

Volltextzugriff (PDF)

Les Ancêtres

1, 2012

Volltextzugriff (PDF)

Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia

JAMA ophthalmology, 2024-05, Vol.142 (5), p.417

2024

Volltextzugriff (PDF)

COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)

Hematological oncology, 2017-06, Vol.35 (S2), p.119-120

2017

Volltextzugriff (PDF)

Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (MCRC): Overall Survival Update

Annals of oncology, 2012-09, Vol.23, p.ixe10

2012

Volltextzugriff (PDF)

Safety and efficacy of sorafenib in elderly patients (pts) ≥65 years: A subset analysis from the Advanced Renal Cell Carcinoma Sorafenib (ARCCS) Expanded Access Program in North America

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5045-5045

2008

Volltextzugriff (PDF)

The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial in North America: Safety and efficacy

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5011-5011

2007

Volltextzugriff (PDF)

Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype

Thrombosis and haemostasis, 2005-08, Vol.94 (2), p.412

2005

Volltextzugriff (PDF)

CLASSIFICATION OF STRICT WONDERFUL VARIETIES

Annales de l'Institut Fourier, 2010, Vol.60 (2), p.641-681

2010

Volltextzugriff (PDF)

High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children

The Journal of pediatrics, 1982-01, Vol.100 (4), p.655-660

1982

Volltextzugriff (PDF)

Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla

Progress in brain research, 1988, Vol.78, p.535

1988

Volltextzugriff (PDF)

Multisystemic treatment of violent and chronic juvenile offenders: bridging the gap between research and practice

Administration and policy in mental health and mental health services research, 1997-11, Vol.25 (2), p.221-238

1997

Volltextzugriff (PDF)

Task Force Report on Cautionary Statements in OTC Advertisements

Drug intelligence & clinical pharmacy, 1980-05, Vol.14 (5), p.358-370

1980

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieScience

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)
Bücher
(2)

Sprache

Englisch
(19)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(11)
Animals
(5)
Female
(5)
Biological And Medical Sciences
(4)
Male
(4)
Receptors, Thrombin - Genetics
(4)
Adolescent
(3)
Adult
(3)
Aged
(3)
Hematology
(3)
Medical Sciences
(3)
Mice
(3)
Middle Aged
(3)
Antineoplastic Agents - Adverse Effects
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Benzenesulfonates - Adverse Effects
(2)
Benzenesulfonates - Therapeutic Use
(2)
Biochemistry & Molecular Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets

Proteolytically Activated Receptor-3: A Member of an Emerging Gene Family of Protease Receptors Expressed on Vascular Endothelial Cells and Platelets

Platelets express steroidogenic 17β–hydroxysteroid dehydrogenases: Distinct profiles predict the essential thrombocythemic phenotype

IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization

Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells

Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization

The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand

Figures de la Cruauté

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Les Ancêtres

Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia

COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program

Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (MCRC): Overall Survival Update

Safety and efficacy of sorafenib in elderly patients (pts) ≥65 years: A subset analysis from the Advanced Renal Cell Carcinoma Sorafenib (ARCCS) Expanded Access Program in North America

The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial in North America: Safety and efficacy

Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype

CLASSIFICATION OF STRICT WONDERFUL VARIETIES

High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children

Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla

Multisystemic treatment of violent and chronic juvenile offenders: bridging the gap between research and practice

Task Force Report on Cautionary Statements in OTC Advertisements

Aktive Filter

Suchergebnisse filtern